Royalty Pharma Acquires Royalty Interest in RotaTeq® from The Children’s Hospital Foundation for $182 Million

New York, NY, April 23, 2008 – The Children’s Hospital Foundation, the parent company of The Children’s Hospital of Philadelphia® (CHOP) and Royalty Pharma announced today that the Foundation has sold its worldwide royalty interest in respect of sales of RotaTeq® from and after October 1, 2007, to Royalty Pharma for $182 million in cash.

Source: Original Article